Glyburide transport across the human placenta

Obstetrics and Gynecology

Volumn 125, Issue 3, 2015, Pages 583-588

  Schwartz, Rachelle A ^a,b   Rosenn, Barak ^a,b   Aleksa, Katarina ^a,b   Koren, Gideon ^a,b  

^a All Children's Hospital Perinatology Specialists   (Russian Federation)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; ANTIDIABETIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; MATERNAL BLOOD; MATERNAL SERUM; OBSERVATIONAL STUDY; PLACENTAL TRANSFER; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; DIABETES, GESTATIONAL; FETOMATERNAL TRANSFUSION; FETUS BLOOD; METABOLISM; PREGNANCY;

ADULT; DIABETES, GESTATIONAL; FEMALE; FETAL BLOOD; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PROSPECTIVE STUDIES;

EID: 84923585084     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000672     Document Type: Article

References (20)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37(suppl 1):S81-90.
2. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus: the organizing committee. Diabetes Care 1998;21(suppl 2):B161-7.
3. Coustan DR. Gestational diabetes. In: National Institutes of Diabetes and Digestive and Kidney Diseases. Diabetes in America. 2nd ed. Bethesda (MD): NIDDK; 1995. p. 703-17.
4. Greene MF. Oral hypoglycemic drugs for gestational diabetes. N Engl J Med 2000;343:1178-9.
5. Elliot BD, Langer O, Schenker S, Johnson RF. Insignificant transfer of glyburide occurs across the placenta. Am J Obstet Gynecol 1991;165:807-12.
6. Elliot BD, Schenker S, Langer O, Johnson R, Prihoda T. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental transfer. Am J Obstet Gynecol 1994;171:653-60.
7. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-8.
8. Naraharisetti SB, Kirby BJ, Hebert MF, Easterling TR, Unadkat JD. Validation of a sensitive LC-MS assay for quantification of glyburide and its metabolite 4-transhydroxy glyburide in plasma and urine: an OPRU Network Study. J Chromatogr B Analyt Technol Biomed Life Sci 2007;860: 34-41.
9. Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, et al. Are we optimizing gestational diabetes treatment with glyburide?. The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 2009;85:607-14.
10. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82.
11. American Diabetes Association. Standards of medical care in Diabetes-2012. Diabetes Care 2012;35(suppl 1):S11-63.
12. Gedeon C, Kapur B, Aleska K, Koren G. A simple and rapid HPLC method for the detection of glyburide in plasma. Clin Biochem 2008;41:167-73.
13. Kraemer J, Klein J, Lubetsky A, Koren G. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol 2006;195:270-4.
14. Gedeon C, Anger G, Piquette-Miller M, Koren G. Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta. Placenta 2008;29: 39-43.
15. Pollex EK, Anger G, Hutson J, Koren G, Piquette-Miller M. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism. Drug Metab Dispos 2010;38:740-4.
16. Brustman L, Langer O, Scarpelli S, Daouk M, Fuchs A, Rosenn B. Hypoglycemia in glyburide-treated gestational diabetes: is it dose dependent?. Obstet Gynecol 2011;117:349-53.
17. Langer O, Yogev Y, Xenakis EM, Rosenn B. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol 2005;192:134-9.
18. Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol 2004;190:1438-9.
19. Prendergast BD. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents. Clin Pharm 1984;3:473-85.
20. Committee on Fetus and Newborn, Adamkin DH. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics 2011;127:575-9.